AMPHETAMINE-LIKE EFFECT OF L-DEPRENYL (SELEGILINE) IN DRUG DISCRIMINATION STUDIES

Authors
Citation
S. Yasar et J. Bergman, AMPHETAMINE-LIKE EFFECT OF L-DEPRENYL (SELEGILINE) IN DRUG DISCRIMINATION STUDIES, Clinical pharmacology and therapeutics, 56(6), 1994, pp. 768-773
Citations number
31
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00099236
Volume
56
Issue
6
Year of publication
1994
Part
2
Supplement
S
Pages
768 - 773
Database
ISI
SICI code
0009-9236(1994)56:6<768:AEOL(I>2.0.ZU;2-Q
Abstract
l-Deprenyl has dose-dependent amphetamine- and methamphetamine-like di scriminative stimulus properties in rats and monkeys. However, these a ctions occur only at doses that are well above the clinically relevant dose range for l-deprenyl and are likely to reflect its metabolic con version to amphetamine products. In view of its weak potency for produ cing amphetamine-like effects and their slow onset, it may not be surp rising that l-deprenyl does not appear to have amphetamine-like abuse potential and has been used therapeutically in the treatment of Parkin son syndrome for more than 20 years with no reported instances of abus e.